Mikael K. P.
- Country
- Denmark
- Department
- Cardiology
Research Overview
- A Double-Blind, Randomized, Placebo-Controlled Trial of Vericiguat in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF) Using CardioMEMS™ HF System
- Comparative Efficacy of Carvedilol and Metoprolol Succinate in Heart Failure Patients with Reduced Ejection Fraction: A Cluster and Registry Trial
Data & Insights
Has run more than one trial at 1 of 3 partner sites.
Specializations
Cardiovascular disease and cardiac surgery
Clinical research activity centers on atherosclerotic cardiovascular disease, acute myocardial infarction, atrial fibrillation, heart failure, and cardiac arrest, with additional interest in perioperative care for coronary artery bypass grafting and aortic valve surgery.
- Acute coronary syndromes
- Heart failure with reduced or preserved ejection fraction
- Postoperative atrial fibrillation
- Cardiac arrest and resuscitation
Therapeutic focus also includes lipid-lowering strategies, antithrombotic treatment, and inflammation-targeted approaches in high-risk cardiovascular settings.
Hematologic malignancies and plasma cell disorders
The investigator is involved in studies across lymphoma, leukemia, multiple myeloma, and amyloidosis, including relapsed and high-risk disease states requiring advanced therapeutic options.
- Diffuse large B-cell lymphoma
- Chronic lymphocytic leukemia
- Multiple myeloma
- Light chain amyloidosis
Research interest extends to immune-based and targeted approaches in difficult-to-treat hematologic cancers.
Inflammatory and autoimmune disorders
Clinical trial involvement includes Crohn’s disease, ulcerative colitis, psoriatic arthritis, systemic lupus erythematosus, vasculitis, and myasthenia gravis, reflecting a broad interest in immune-mediated disease control.
- Inflammatory bowel disease
- Systemic autoimmune disease
- Chronic inflammatory neuropathy
- Severe asthma and eosinophilic airway disease
Therapeutic domains include biologic and targeted immunomodulatory treatments for chronic inflammatory conditions.
Oncology and solid tumors
Research activity also spans breast cancer, lung cancer, colorectal cancer, ovarian cancer, bladder cancer, and prostate cancer, with interest in both localized and metastatic disease.
- Breast and gynecologic cancers
- Gastrointestinal malignancies
- Thoracic cancers
- Urologic cancers
Therapeutic emphasis includes immunotherapy, targeted therapy, and biomarker-informed treatment strategies.
Rare disease, neurology, and organ-specific disorders
The investigator is additionally engaged in studies of indolent systemic mastocytosis, idiopathic pulmonary fibrosis, pulmonary sarcoidosis, IgA nephropathy, primary sclerosing cholangitis, and neurologic disease such as diffuse glioma and multiple sclerosis.
- Fibrotic lung disease
- Kidney disease with proteinuria
- Central nervous system tumors
- Rare mast cell and amyloid disorders
Therapeutic interest includes disease-modifying treatment for uncommon chronic conditions and organ-threatening complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.